Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical management

被引：7
|
作者：
Bartoli, Carlo R. [1 ]
机构：
[1] Hosp Univ Penn, Div Cardiovasc Surg, 380 South Univ Ave,Hill Pavilion,Room 410B, Philadelphia, PA 19104 USA
来源：
ANNALS OF CARDIOTHORACIC SURGERY | 2021年 / 10卷 / 03期
关键词：
PULSATILITY;
D O I：
10.21037/acs-2020-cfmcs-29
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：389 / 392
页数：4
相关论文
共 50 条
  • [21] Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation
    Kang, Jooeun
    Zhang, David M.
    Restle, David J.
    Kallel, Faouzi
    Acker, Michael A.
    Atluri, Pavan
    Bartoli, Carlo R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (06): : 1747 - +
  • [22] The "double whammy" of a continuous-flow left ventricular assist device on von Willebrand factor
    Hydren, Jay R.
    Richardson, Russell S.
    Wever-Pinzon, Omar
    Drakos, Stavros G.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (03): : 910 - 915
  • [23] Bleeding in critical care associated with left ventricular assist devices: pathophysiology, symptoms, and management
    Leebeek, F. W. G.
    Muslem, R.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 88 - 96
  • [24] Hemolysis and Von Willebrand Factor Levels During Continuous Flow Left Ventricular Assist Device Support
    Saeed, O.
    Rangasamy, S.
    Luke, A.
    Patel, S. R.
    Shin, J.
    Sims, D. B.
    Gil, M. Reyes
    Goldstein, D. J.
    Slepian, M. J.
    Billett, H. H.
    Jorde, U.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S247 - S247
  • [25] von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support
    Nascimbene, Angelo
    Hilton, Tristan
    Konkle, Barbara A.
    Moake, Joel L.
    Frazier, O. H.
    Dong, Jing-fei
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : 477 - 479
  • [26] Comparative Analysis of von Willebrand Factor Profiles in Pulsatile and Continuous Left Ventricular Assist Device Recipients
    Crow, Sheri
    Milano, Carmelo
    Joyce, Lyle
    Chen, Dong
    Arepally, Gowthami
    Bowles, Dawn
    Thomas, William
    Ortiz, Nestor Villamizar
    ASAIO JOURNAL, 2010, 56 (05) : 441 - 445
  • [27] Impact of a Novel Accessory for Left Ventricular Assist Devices on Hemolysis and Degradation of Von Willebrand Factor In Vitro
    Meissner, F.
    Eichelkraut, D.
    Schimmel, M.
    Buechsel, M.
    Schoen, M.
    Vestner, H.
    Galbas, M. Costa
    Czerny, M.
    Bothe, W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S496 - S497
  • [28] Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome
    Deconinck, Shannen
    Tersteeg, Claudia
    Bailleul, Els
    Delrue, Leen
    Vandeputte, Nele
    Pareyn, Inge
    Itzhar-Baikian, Nathalie
    Deckmyn, Hans
    De Meyer, Simon F.
    Vanderheyden, Marc
    Vanhoorelbeke, Karen
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (04) : 762 - 766
  • [29] Bleeding and Angiogenesis During Continuous-Flow Left Ventricular Assist Device Support Enter the von Willebrand Matrix
    Saeed, Omar
    Patel, Snehal R.
    Jorde, Ulrich P.
    CIRCULATION-HEART FAILURE, 2018, 11 (09)
  • [30] Comparative analysis of von Willebrand factor profiles in left ventricular assist device and total artificial heart recipients
    Reich, H. J.
    Arabia, F. A.
    Czer, L.
    Moriguchi, J.
    Ramzy, D.
    Esmailian, F.
    Lam, L.
    Dunhill, J. A.
    Tcherniantchouk, O.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 177 - 178
12345